Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs GetRelief Rx

CoreAge Rx
Graded #1

Higher grade

vs+33.199999999999996
GetRelief Rx
Graded #365

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 58.6/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +50
92
42
Dose & formulationCoreAge Rx +10
88
78
Clinical oversightCoreAge Rx +23
93
70
Labs & monitoringCoreAge Rx +38
90
52
FulfillmentCoreAge Rx +37
95
58
Contract termsCoreAge Rx +49
96
47
CoreAge Rx · left barGetRelief Rx · right bar

The numbers

MetricCoreAge RxGetRelief Rx
WeighScore91.8/10058.6/100
GradeA−C
Scorecard rank#1#365
Semaglutide$149/mo$269/mo (9 mg dose, compounded oral)
Tirzepatide$349/mo$179/mo (16 mg dose, compounded oral)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
GetRelief Rx

Graded #365 · C

Strengths

  • Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
  • BBB accredited with an A rating (March 2026)
  • Free online assessment with no upfront consultation fee

Where it loses points

  • Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
  • Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
  • No LegitScript, PCAB, or NABP pharmacy certifications found
  • Prescriber credentials listed only as 'licensed clinicians' with no detail on degree type

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard